trans-3-pentenoic acid → HCID 178447395, compound
Reaction equation
Cl.Cl.Cl.[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH2:27])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1.[C:28](O)(=[O:33])[CH2:29]/[CH:30]=[CH:31]/[CH3:32]>>[O:4]1[C:8]2=[C:9]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH:27][C:28](=[O:33])[CH2:29]/[CH:30]=[CH:31]/[CH3:32])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[N:10]=[CH:11][CH:12]=[C:7]2[CH2:6][CH2:5]1Participants
3
Procedure
The title compound, white solid (92 mg, 89%), MS (ISP) m/z=413.4 [(M+H)+], mp 170° C., was prepared in accordance with the general method of example 6 from trans-4-{2-[4-(2,3-dihydro-furo[2,3-c]pyridin-7-yl)-piperazin-1-yl]-ethyl}-cyclohexylamine trihydrochloride (intermediate B) (110 mg, 0.25 mmol) and (E)-pent-3-enoic acid.
Sources & evidence
- ORD record
- ord-a7ef2310631142c1825458e3887d81ae
- Source dataset
- uspto-grants-2013_06
- Patent number
- US08470828B2
Reaction notes
Loading…